Omalizumab treatment downregulates dendritic cell FcεRI expression

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 6, 2003, Pages 1147-1154

  Prussin, Calman ^a,c   Griffith, Daniel T ^b   Boesel, Kevin M ^b   Lin, Henry ^b   Foster, Barbara ^a   Casale, Thomas B ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Anti IgE; Antigen presenting cells; Dendritic cells; Fc RI; IgE; Omalizumab

Indexed keywords

FC EPSILON RECEPTOR; FC RECEPTOR; IMMUNOGLOBULIN E; OMALIZUMAB; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ARTICLE; CELL SUBPOPULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; DENDRITIC CELL TYPE 1; DENDRITIC CELL TYPE 2; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; UNITED STATES;

EID: 0347364816     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2003.10.003     Document Type: Article

References (24)

1. Prussin C, Metcalfe DD. 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2003;111(suppl):S486-94.
2. Novak N, Kraft S, Bieber T. Unraveling the mission of FcεRI on antigen-presenting cells. J Allergy Clin Immunol 2003;111:38-44.
3. Maurer D, Fiebiger E, Reininger B, Ebner C, Petzelbauer P, Shi GP, et al. Fc ε receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation. J Immunol 1998;161:2731-9.
4. Larche M, Haselden BM, Oldfield WL, Shirley K, North J, Meng Q, et al. Mechanisms of T cell peptide epitope-dependent late asthmatic reactions. Int Arch Allergy Immunol 2001;124:272-5.
5. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002;2:151-61.
6. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863-9.
7. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283:1183-6.
8. Boonstra A, Asselin-Paturel C, Gilliet M, Crain C, Trinchieri G, Liu YJ, et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 2003;197:101-9.
9. Casale TB. Experience with monoclonal antibodies in allergic mediated disease: seasonal allergic rhinitis. J Allergy Clin Immunol 2001;108 (suppl):S84-8.
10. Boushey HA Jr. Experiences with monoclonal antibody therapy for allergic asthma. J Allergy Clin Immunol 2001;108(suppl):S77-83.
11. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J, et al. Down-regulation of Fc(ε)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-45.
12. Saini SS, MacGlashan D. How IgE upregulates the allergic response. Curr Opin Immunol 2002;14:694-7.
13. Casale TB, Bernstein IL: Busse WW, LaForce CF, Tinkelman DG, Stoltz RR, et al. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:110-21.
14. Foster B, Schwartz LB, Devouassoux G, Metcalfe DD, Prussin C. Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils. J Allergy Clin Immunol 2002;109:287-93.
15. Foster B, Prussin C. Detection of intracellular cytokines by flow cytometry. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. editors. Current protocols in immunology. Hoboken (NJ): Wiley: 2003. p. 6.24.1-6.24.16.
16. Boesel KM, Griffith DT, Prussin C, Foster B, Lin H, Casale TB. Rapid reduction of basophil FcRI expression by omalizumab. J Allergy Clin Immunol 2003;111(suppl):S264.
17. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000;165: 6037-46.
18. Borkowski TA, Jouvin MH, Lin SY, Kinet JP. Minimal requirements for IgE-mediated regulation of surface Fc ε RI. J Immunol 2001;167:1290-6.
19. Dzionek A, Inagaki Y, Okawa K, Nagafune J, Rock JJ, Sohma Y, et al. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions(1). Hum Immunol 2002;63:1133-48.
20. Feuchtinger T, Bartz H, von Berg A, Riedinger F, Brauburger J, Stenglein S, et al. Treatment with omalizumab normalizes the number of myeloid dendritic cells during the grass pollen season. J Allergy Clin Immunol 2003;111:428-30.
21. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001;2:725-31.
22. Uchida Y, Kurasawa K, Nakajima H, Nakagawa N, Tanabe E, Sueishi M, et al. Increase of dendritic cells of type 2 (DC2) by altered response to IL-4 in atopic patients. J Allergy Clin Immunol 2001;108:1005-11.
23. Holloway JA, Holgate ST, Semper AE. Expression of the high-affinity IgE receptor on peripheral blood dendritic cells: differential binding of IgE in atopic asthma. J Allergy Clin Immunol 2001;107:1009-18.
24. Matsuda H, Suda T, Hashizume H, Yokomura K, Asada K, Suzuki K, et al. Alteration of balance between myeloid dendritic cells and plasmacytoid dendritic cells in peripheral blood of patients with asthma. Am J Respir Crit Care Med 2002;166:1050-4.